首页> 外国专利> Compound, pharmaceutical composition, its uses, method for enhancing cholinergic receptor activity, methods for treating or preventing mental disorder, pain, increased intraocular pressure, and progression or formation of amyloid plaques.

Compound, pharmaceutical composition, its uses, method for enhancing cholinergic receptor activity, methods for treating or preventing mental disorder, pain, increased intraocular pressure, and progression or formation of amyloid plaques.

机译:化合物,药物组合物,其用途,增强胆碱能受体活性的方法,治疗或预防精神障碍,疼痛,眼内压升高以及淀粉样斑块进展或形成的方法。

摘要

"COMPOUND, PHARMACEUTICAL COMPOSITION, ITS USES, METHOD FOR INCREASING ACTIVITY OF A CHolinergic RECEIVER, METHODS FOR TREATMENT OR PREVENTION OF MENTAL DISTURBANCE, PAIN, INCREASED INTRAOCULAR PRESSURE AND PROGRESS. Benzimidazolidinone-derived compounds that enhance the signaling or effect of acetylcholine in the brain and highly selective muscarinic agonists, in particular for M-1 and / or M-4 receptor subtypes, pharmaceutical compositions comprising them, as well as methods for treatment of psychoses through the use of these compounds.
机译:“化合物,药物成分及其用途,增强胆碱能受体的活性的方法,治疗或预防精神障碍的方法,疼痛,眼内压升高和进展。苯并咪唑啉酮衍生的脑乙酰苯并咪唑烷酮化合物增强了信号传导或作用和高度选择性的毒蕈碱激动剂,特别是针对M-1和/或M-4受体亚型的毒蕈碱激动剂,包括它们的药物组合物,以及通过使用这些化合物治疗精神病的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号